Pharma Tech Industries Appoints BD Director

From DCAT Value Chain Insights (VCI)

By People On The Move posted 01-12-2015 04:45


Pharma Tech Industries, a pharmaceutical contract manufacturers and packagers of powder products, has added Dennis J. Kinsey as director of business development. With more than 30 years of industry experience, Mr. Kinsey has applied his supply chain and operations expertise at such companies as Johnson & Johnson, GlaxoSmithKline’s Consumer Healthcare division, AstraZeneca and, most recently, Insight Pharmaceuticals.

Kinsey replaces Carl Oberg, who has retired following 13 years of service to Pharma Tech. Mr. Oberg has helped Mr. Kinsey transition his sales and account management responsibilities, which involve developing and supervising Pharma Tech account management employees and targeting new sales opportunities with new and existing customers.

Mr. Kinsey will work closely with Rich Loughlin, vice-presidient of strategic sales, and be a major part of Pharma Tech’s continued growth plans. In addition to Mr. Kinsey’s hiring, Pharma Tech has undergone a major corporate rebranding initiative, added an analytical laboratory for both prescription and over-the-counter drugs in its Royston, Georgia, production facility, and is nearing completion on a multi-million-dollar expansion of its manufacturing plant in Union, Missouri.

A Lean Six Sigma Green Belt, Kinsey is on the supply chain committee of the Consumer HealthCare Products Association and belongs to the American Inventory Control Society. He holds a bachelor of science degree in business management from Villanova University and is currently a master in business administration candidate in the University of Pennsylvania’s Wharton School.

Source: Pharma Tech Industries


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription